GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chunghwa Chemical Synthesis & Biotech Co Ltd (TPE:1762) » Definitions » Price-to-Funds-From-Operations

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Price-to-Funds-From-Operations : (As of Dec. 14, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chunghwa Chemical Synthesis & Biotech Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.